Sage Therapeutics (SAGE) PT Raised to $68 at BofA Securities
Tweet
Share
E-mailGet Alerts SAGE Hot Sheet
Price: $8.68 --0%
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 46
Rating Summary:
3 Buy, 25 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 11 | New: 46
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad raised the price target on Sage Therapeutics (NASDAQ: SAGE) to $68.00 (from $66.00) while maintaining a Buy rating.
You May Also Be Interested In
- Travere Therapeutics (TVTX) PT Raised to $89 at Guggenheim
- Okta, Inc (OKTA) PT Raised to $215 at Stifel
- Ethos Technologies (LIFE) PT Raised to $38 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
